Disgraced Theranos Founder Elizabeth Holmes Featured in New R-Rated Documentary Trailer
San Francisco, Friday, 25 September 2026.
Director Nathan Fielder lived with Theranos founder Elizabeth Holmes before her imprisonment for an unprecedented R-rated A24 documentary examining executive accountability, scheduled for release October 16, 2026.
Documentary Trailer Release and Content Overview
On September 23, 2026, film distributor A24 released a full-length trailer for the documentary titled “You Can See Everything,” directed by Nathan Fielder and Lance Oppenheim [1][2]. The 174-minute film features unprecedented access to Theranos founder Elizabeth Holmes, including scenes filmed 34 days before she was sent to prison [2]. The Motion Picture Association has assigned the film an R rating due to language and graphic nudity, marking a distinct approach to documenting corporate governance failures [1]. This media portrayal continues to draw executive interest as the industry examines the cultural focus on the Theranos scandal [1].
Legal Background and Conviction Details
Elizabeth Holmes was convicted of three counts of wire fraud and one count of attempting to commit wire fraud involving $140 million in investor losses [1]. A federal grand jury initially indicted Holmes and her former business partner Ramesh “Sunny” Balwani on fraud charges in June 2018 [2]. Her trial ended in January 2022, resulting in conviction for defrauding investors, though she was acquitted of defrauding patients [2]. Holmes began serving her 11-year sentence at a federal prison camp in Texas on May 30, 2023 [2].
Production Insights and Future Timeline
The documentary production timeline captures Holmes prior to her imprisonment, offering a view into her life before incarceration [2]. According to production notes, Holmes is scheduled to be transferred to a halfway house in August 2027, though this status remains pending verification [1][alert! ‘Source indicates deadline check status is pending’]. The film’s release on October 16, 2026, will provide further public insight into the governance failures associated with Theranos [1][2]. This scheduled release date is confirmed for theaters broadly [2].